242 related articles for article (PubMed ID: 30912046)
1. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
2. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.
Brandão KO; Grandela C; Yiangou L; Mummery CL; Davis RP
Methods Mol Biol; 2022; 2454():531-557. PubMed ID: 33755904
[TBL] [Abstract][Full Text] [Related]
4. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
Getachew H; Chinchilla B; Fernandez-Godino R
Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
Benetó N; Grinberg D; Vilageliu L; Canals I
Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
Petazzi P; Menéndez P; Sevilla A
Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
[TBL] [Abstract][Full Text] [Related]
7. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A
Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268
[TBL] [Abstract][Full Text] [Related]
8. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
[TBL] [Abstract][Full Text] [Related]
9. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
10. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
Xu H; Kita Y; Bang U; Gee P; Hotta A
STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
[TBL] [Abstract][Full Text] [Related]
11. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
[TBL] [Abstract][Full Text] [Related]
12. Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas.
Dolan AE; Hou Z; Xiao Y; Gramelspacher MJ; Heo J; Howden SE; Freddolino PL; Ke A; Zhang Y
Mol Cell; 2019 Jun; 74(5):936-950.e5. PubMed ID: 30975459
[TBL] [Abstract][Full Text] [Related]
13. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
Thamodaran V; Rani S; Velayudhan SR
Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
[TBL] [Abstract][Full Text] [Related]
14. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.
Kim S; Kim D; Cho SW; Kim J; Kim JS
Genome Res; 2014 Jun; 24(6):1012-9. PubMed ID: 24696461
[TBL] [Abstract][Full Text] [Related]
16. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
17. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
19. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
Liu GG; Li S; Wei YD; Zhang YX; Ding QR
Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]